Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design
Paul G. Wyatt, Andrew J. Woodhead (Lead / Corresponding author), Valerio Berdini, John A. Boulstridge, Maria G. Carr, David M. Cross, Deborah J. Davis, Lindsay A. Devine, Theresa R. Early, Ruth E. Feltell, E. Jonathan Lewis, Rachel L. McMenamin, Eva F. Navarro, Michael A. O'Brien, Marc O'Reilly, Matthias Reule, Gordon Saxty, Lisa C. A. Seavers, Donna-Michelle Smith, Matt S. SquiresGary Trewartha, Margaret T. Walker, Alison J. -A. Woolford
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design'. Together they form a unique fingerprint.